首页>化工字典>按产品名称排序

 产品排序

按产品名称排序
按CAS 登录号排序
按字母排序

 热门搜索

 化工字典

CAS号 中文名称 英文名称
606096-63-3 (9CI)-N-1,3-苯并二氧杂环戊烯l-5-基-5-(1-甲基乙基)-7-(三氟甲基)-吡唑并[1,5-a]嘧啶-2-羧酰胺 Pyrazolo[1,5-a]pyrimidine-2-carboxamide, n-1,3-benzodioxol-5-yl-5-(1-methylethyl)-7-(trifluoromethyl)-(9ci)
606096-60-0 (9CI)-5-环丙基-N-[5-(1-甲基乙基)-1,3,4-噻二唑-2-基]-7-(三氟甲基)-吡唑并[1,5-a]嘧啶-2-羧酰胺 Pyrazolo[1,5-a]pyrimidine-2-carboxamide, 5-cyclopropyl-n-[5-(1-methylethyl)-1,3,4-thiadiazol-2-yl]-7-(trifluoromethyl)-(9ci)
107569-03-9 (9ci)-1,3-二甲基-7,7-双(3-甲基-2-丁烯)-9-(苯基甲基)-嘧啶并[2,1-f]嘌呤-2,4,6,8(1h,3h,7h,9h)-四酮 Pyrimido[2,1-f]purine-2,4,6,8(1h,3h,7h,9h)-tetrone,1,3-dimethyl-7,7-bis(3-methyl-2-butenyl)-9-(phenylmethyl)-(9ci)
706804-85-5 (9ci)-4-[4-(1,1-二甲基乙基)苯基]-1-[[3-甲基-4-(1-甲基乙基)-5-氧代-2(5h)-异噁唑基]羰基]-哌啶 Piperidine, 4-[4-(1,1-dimethylethyl)phenyl]-1-[[3-methyl-4-(1-methylethyl)-5-oxo-2(5h)-isoxazolyl]carbonyl]-(9ci)
1262849-79-5 (3r,4s)-rel-4-[(2-氯-6,7-二甲氧基-4-喹唑啉)氨基]-1,3-吡咯烷二羧酸 1-(1,1-二甲基乙基) 3-乙酯 1,3-Pyrrolidinedicarboxylic acid, 4-[(2-chloro-6,7-dimethoxy-4-quinazolinyl)amino]-, 1-(1,1-dimethylethyl) 3-ethyl ester, (3r,4s)-rel-
868565-55-3 (3s)-5-溴-4-氧代-3-[[(2s)-1-氧代-2-[[(苯基甲氧基)羰基]氨基]丙基]氨基]-戊酸 1,1-二甲基乙酯 Pentanoic acid, 5-bromo-4-oxo-3-[[(2s)-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]propyl]amino]-, 1,1-dimethylethyl ester, (3s)-
89331-52-2 N-[2-[[3-[[[1-[4-(二甲基氨基)苯基]亚乙基]氨基]氧基]-2-羟基丙基]氨基]乙基]-2-甲基-丙酰胺 Propanamide,n-[2-[[3-[[[1-[4-(dimethylamino)phenyl]ethylidene]amino]oxy]-2-hydroxypropyl]amino]ethyl]-2-methyl-
861416-05-9 4-[3-[5-(1-甲基乙基)-2,5-二氮杂双环[2.2.1]庚-2-基]-1H-吲唑-1-基]-n-[(1s)-1-苯基乙基]-2-吡啶胺 2-Pyridinamine,4-[3-[5-(1-methylethyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]-1h-indazol-1-yl]-n-[(1s)-1-phenylethyl]-
102212-69-1 7-[2-(乙基磺酰基)乙基]-6-羟基-1,3-二甲基-9-(苯基甲基)-嘧啶并[2,1-f]嘌呤-2,4,8(1H,3H,9H)-三酮 Pyrimido[2,1-f]purine-2,4,8(1h,3h,9h)-trione, 7-[2-(ethylsulfonyl)ethyl]-6-hydroxy-1,3-dimethyl-9-(phenylmethyl)-
91285-23-3 7-[2-(二甲基氨基)乙基]-6-羟基-1,3-二甲基-9-(苯基甲基)-嘧啶并[2,1-f]嘌呤-2,4,8(1H,3H,9H)-三酮 Pyrimido[2,1-f]purine-2,4,8(1h,3h,9h)-trione, 7-[2-(dimethylamino)ethyl]-6-hydroxy-1,3-dimethyl-9-(phenylmethyl)-
91285-17-5 7-[2-(乙酰基氧基)乙基]-6-羟基-1,3-二甲基-9-(苯基甲基)-嘧啶并[2,1-f]嘌呤-2,4,8(1H,3H,9H)-三酮 Pyrimido[2,1-f]purine-2,4,8(1h,3h,9h)-trione, 7-[2-(acetyloxy)ethyl]-6-hydroxy-1,3-dimethyl-9-(phenylmethyl)-
606110-37-6 (9CI)-2,6-二甲基-1-[[2-[[2-(4-甲基-1-哌啶基)-2-氧代乙基]硫代]-1H-苯并咪唑-1-基]乙酰基]-哌啶 Piperidine, 2,6-dimethyl-1-[[2-[[2-(4-methyl-1-piperidinyl)-2-oxoethyl]thio]-1h-benzimidazol-1-yl]acetyl]-(9ci)
606110-11-6 (9CI)-2,6-二甲基-1-[[[1-[2-(4-甲基-1-哌啶基)-2-氧代乙基]-1H-苯并咪唑-2-基]硫代]乙酰基]-哌啶 Piperidine, 2,6-dimethyl-1-[[[1-[2-(4-methyl-1-piperidinyl)-2-oxoethyl]-1h-benzimidazol-2-yl]thio]acetyl]-(9ci)
71539-01-0 PHE-NLE-HIS-ASN-LEU-GLY-LYS-HIS-LEU-SER-SER-NLE-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-TYR-NH2 Parathyroid hormone (7-34) amide, tyr(34)-
706804-99-1 (9ci)-1-[[3-甲基-4-(1-甲基乙基)-5-氧代-2(5h)-异噁唑基]羰基]-4-(5-甲基-1,3,4-噁二唑-2-基)-哌啶 Piperidine, 1-[[3-methyl-4-(1-methylethyl)-5-oxo-2(5h)-isoxazolyl]carbonyl]-4-(5-methyl-1,3,4-oxadiazol-2-yl)-(9ci)
176379-27-4 n-(6-氨基-1,2,3,4-四氢-3-甲基-2,4-二氧代-1-苯基-5-嘧啶)-3-[3,4-双(乙酰基氧基)苯基]-2-丙酰胺 2-Propenamide, n-(6-amino-1,2,3,4-tetrahydro-3-methyl-2,4-dioxo-1-phenyl-5-pyrimidinyl)-3-[3,4-bis(acetyloxy)phenyl]-
1422264-48-9 (2s)-1-[3-[4-(5,10-二氢-3-甲基噻唑并[3,2-b][2,4]苯并二氮杂革-2-基)苯氧基]丙基]-2-吡咯烷甲醇 2-Pyrrolidinemethanol, 1-[3-[4-(5,10-dihydro-3-methylthiazolo[3,2-b][2,4]benzodiazepin-2-yl)phenoxy]propyl]-, (2s)-
478341-98-9 (9CI)-N-[2-(环己基氨基)-1-(1,3-二甲基-1H-吡唑-4-基)-2-氧代乙基]-N-(4-苯氧基苯基)-吡嗪羧酰胺 Pyrazinecarboxamide, n-[2-(cyclohexylamino)-1-(1,3-dimethyl-1h-pyrazol-4-yl)-2-oxoethyl]-n-(4-phenoxyphenyl)-(9ci)
606135-61-9 (9CI)-N-[(4-氟苯基)甲基]-N-(5-甲基-3-异噁唑基)-N-[2-氧代-2-[(2-苯基乙基)氨基]乙基]-戊二酰胺 Pentanediamide, n-[(4-fluorophenyl)methyl]-n-(5-methyl-3-isoxazolyl)-n-[2-oxo-2-[(2-phenylethyl)amino]ethyl]-(9ci)
898044-54-7 3-氨基-n-[(1s)-2-(二甲基氨基)-1-苯基乙基]-4,6-二氢-6,6-二甲基-吡咯并[3,4-c]吡唑-5(1h)-羧酰胺 Pyrrolo[3,4-c]pyrazole-5(1h)-carboxamide, 3-amino-n-[(1s)-2-(dimethylamino)-1-phenylethyl]-4,6-dihydro-6,6-dimethyl-
第一页 前20页 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 最后页 

上海丹帆网络科技有限公司 版权所有 (C)2003-2024